Oakwood Medical Investors is a life sciences venture capital fund formed to invest in development stage medical device, biopharmaceutical and healthcare service companies. Target portfolio companies for Oakwood have an outstanding management team, industry disruptive technology, demonstrated proof of concept and have typically completed a first round of institutional venture financing.
The Managing Partners of Oakwood Medical Investors bring a unique blend of experience from the perspective of a physician, scientist-engineer, investment banker and attorney. Oakwood's founders have collaborated over the past 22 years on investments in over 40 privately-held medical device, biopharmaceutical and healthcare service companies. Oakwood's philosophy of "knowledge first" results in the proactive discovery of emerging companies that produces a strong stream of high quality investment opportunities.
Oakwood follows a disciplined end-to-end process to:
• Identify unmet medical needs;
• Discover promising technologies that will be adopted by the medical community;
• Invest in mid-stage healthcare companies that provide differentiated products and technologies; and
• Assist portfolio companies with clinical trials and exits to strategic buyers or through public markets.
Oakwood prides itself on the network it has developed including nationally recognized medical professionals and scientists from leading academic institutions. Oakwood believes that the combination of its scientific knowledge base, life sciences investment experience, and broad and complimentary experience of its principals creates a powerful partner for development stage companies.
Oakwood Medical Investors. Investing to Advance Health Care.